Form 4: Boston Scientific Director Acquires Shares

Boston Scientific Corp. director Ellen M. Zane acquired 3,800 shares of common stock through an annual equity award.

Summary

• Ellen M. Zane, a Director at Boston Scientific Corp., acquired 3,800 shares of common stock on May 7, 2026.
• This acquisition was part of an annual equity award, with the shares vesting in full upon the next annual meeting of stockholders.
• The value of the award was $215,000, based on the closing price of common stock on the grant date.
• Following this transaction, Zane beneficially owns 27,934 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider equity award and does not contain significant new financial information or strategic shifts.

Positives

• Director Ellen M. Zane received an equity award, indicating continued alignment with shareholder interests.
• The award vests upon the next annual meeting, suggesting a commitment to the company's near-term future.

Future Outlook

The equity award vests in full upon the next annual meeting of stockholders, indicating a near-term future event for the vesting of these shares.

Industry Context

StockSavvy.ai notes that insider equity awards are common in the medical device industry as a tool for executive and director compensation and retention, aligning their interests with long-term company performance.

Stakeholder Impact

• Shareholders: The acquisition by a director reinforces alignment of management and director interests with those of shareholders.

Next Steps

• Vesting of the awarded restricted stock upon the next annual meeting of stockholders.

Key Dates

Keywords

Boston Scientific, BSX, Form 4, Insider Transaction, Equity Award, Director, Stock Acquisition